Letter from the Editor

For Their Transformative Inspiration and Influence

Transformation is easy to define: a thorough or dramatic change in form or appearance.
Transformation is much harder to achieve. For this special — and my favorite — issue we asked this year’s PharmaVOICE 100 to provide a short response to the statement: Transformation is… We received a variety of responses, including: the new disruption, reimagining possibilities, agility, necessary, survival, fearless, opportunity, reconfiguring today, moving beyond the obvious, accelerating effectiveness, taking something to the next level, innovations in science and cures, ongoing, and nothing short of essential.

The men and women showcased in this issue represent a full complement of companies and organizations that define the life-sciences industry. Their powerful stories of leadership, inspiration, innovation, motivation, and mentorship just scratch the surface in terms of their enduring impact on their peers, colleagues, companies, communities, the industry at large, and most importantly, patients.

Through their efforts, they are transforming how brands are developed and messages are communicated. They are agents of change, impacting everything from drug discovery to market access to women’s leadership. They are experts in all things related to clinical operations, from patient recruitment to technology-enhanced solutions. They are C-suite executives charged with leading their companies or divisions with integrity, vision, and compassion. They are breaking new ground by evangelizing digital strategies. They created companies to address gaps in the marketplace. They are experts in marketing, taking their craft to the highest levels. They are dedicated mentors, generously providing guidance to help the next generation of leaders achieve their goals and aspirations — personal and professional.
They are dedicated to representing the patients’ perspective in all they do from the clinic to the boardroom. They are focused on the regulations to move the industry forward. And they are dedicated to having technology be the convener — from data to patients — that moves the industry forward.

The inspirational stories of the PharmaVOICE 100, as well as our Red Jacket honorees, reaffirm what’s good about our industry, which is particularly important today.

Every year, the number of submissions we receive surpasses the previous year, and come from an ever-growing and diverse range of companies representing the global healthcare and the life-sciences industry. We thank those of you who took the time to put forward nominations and for making our job of selecting just 100 individuals ever more difficult. We hope you enjoy their stories. And we hope you will join us in celebrating this year’s esteemed group of individuals, as well as our previous PharmaVOICE 100, September 13 in New York at the fourth annual Celebration. For more information about this unique event, please go to www.pharmavoice.com/pharmavoice-100-celebration-schedule-of-events.

Taren Grom, Editor

~~~~~~~~~~~~~~~~~~~~~~~~~

Their word…

Denise Myshko
Managing Editor

This year’s PharmaVOICE 100 have dedicated their lives to an industry that brings innovative medicines to patients.

Robin Robinson
Senior Editor

This year’s PharmaVOICE 100 illustrate how innovative thinkers are driving industry transformation in 2018 and beyond.

Kim Ribbink
Features Editor

Regardless of the role our honorees play in their organizations, all are committed to making a difference in the lives of patients, clients, colleagues, and communities.

~~~~~~~~~~~~~~~~~~~~~~~~~

Coming in September
Agency: CEO Roundtable
Changing the Channel: A Media-First Approach to Marketing
The Big Business of Biologics
Finding a Board Position
Update: The Brain
Developing The Next Generation of Women Leaders
Showcases:
Big Data
Marketing

~~~~~~~~~~~~~~~~~~~~~~~~~

Masthead

The forum for the industry executive

Volume 18 • Number 7
Publisher Lisa Banket
Editor Taren Grom
Creative Director Marah Walsh

Managing Editor
Denise Myshko

Senior Editor
Robin Robinson

Features Editor
Kim Ribbink

Design Associate
Ariel Medel

Director of Sales
Cathy Tracy

National Account Manager
Suzanne Besse

Webcast Network Producer
Daniel Limbach

Circulation Assistant
Kathy Deiuliis

PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by PharmaLinx LLC, P.O. Box 327, Titusville, NJ 08560. Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.

Postmaster: Send address changes to PharmaVOICE, P.O. Box 292345, Kettering, OH 45429-0345.

PharmaVoice Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.

Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: [email protected].

Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: [email protected].

Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change.

Advertising in PharmaVoice: To advertise in PharmaVoice please contact our Advertising Department at P.O. Box 327, Titusville, NJ 08560, or telephone us at 609.730.0196. E-mail: [email protected].

Letters …

Send your letters to feedback@pharmavoice.com. Please include your name, title, company, and business phone number. Letters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLC.

Download PDF